Clinical Trial Update: "Efficacy Of 1.2% Rosuvastatin Gel In The Management Of Infrabony Defects" [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of 1.2% rosuvastatin gel for managing infrabony defects in adult periodontitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• rosuvastatin gel (rosuvastatin)

Snippet

Sponsor: Dr. D. Y. Patil Dental College & Hospital | Conditions: Adult Periodontitis | Phase 4 | Status: COMPLETED